BOW
Bowhead Specialty Holdings Inc.27.71
-0.36-1.28%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Q&A reaffirms with Baleen LR edge
Q&A largely reaffirmed the scripted 20% GWP growth guidance for 2026 and sub-30% expense ratio, but surfaced Baleen's superior loss ratio versus core casualty as a key differentiator. Management confirmed casualty rates exceeding loss trends directionally amid persistent limit discipline, while tech efficiencies are compressing expenses faster than expected, targeting below low-30s long-term. Reserving relies on tailored proprietary data for conservatism, with no pricing adequacy issues flagged. Analysts pressed on Baleen growth, mix-driven loss ratio shifts, and broker disintermediation; answers were crisp but dodged precise mix quantifies. Baleen gains traction. Confident tone persists, but investors will eye casualty lumpiness.
Key Stats
Market Cap
963.80MP/E (TTM)
17.65Basic EPS (TTM)
1.57Dividend Yield
0%Recent Filings
8-K
GWP surges 24%, loss ratio rises
Bowhead Specialty Holdings reported Q4 2025 results with gross written premiums up 21.3% to $224.1 million, driven by 25.5% Casualty growth and Baleen Specialty's 665.6% surge to $9.1 million. Full-year GWP rose 24.0% to $862.8 million, net income hit $53.8 million, yet loss ratio climbed to 66.7% from 64.4% due to mix shifts and industry-aligned reserves. Digital expansion validates strategy. Expects ~20% GWP growth in 2026.
10-K
FY2025 results
Bowhead Specialty Holdings crushed FY2025 with gross written premiums rocketing 24% y/y to $862.8M, led by Casualty's 27.5% surge to $550.7M (63.8% of total) and Baleen Specialty's explosive 1215% leap to $21.4M, while net earned premiums climbed 27.7% to $491.7M. Q4 momentum accelerated this growth via a maturing renewal book across all divisions, though the loss ratio edged to 66.7% from 64.4% on mix shift toward higher-ratio Casualty and reserve tweaks aligning to industry data; combined ratio held steady at 96.5%. Net income jumped 40.6% to $53.8M, bolstered by $57.8M net investment income (up 44%). Year-end debt stood at $150M Senior Notes (7.75%, 2030 maturity) with $35M revolver undrawn; no dividends or buybacks. Inability to maintain AmFam partnership could cripple operations.
8-K
Bowhead secures $35M revolver
Bowhead Specialty Holdings inked a $35M senior secured revolver with PNC on November 26, 2025, maturing November 26, 2027 (or earlier if MGAs terminate). Funds support growth and working capital at Term SOFR+1.75% or base+0.75%, with covenants capping debt at 35% of capitalization and requiring 400% RBC. No borrowings drawn yet.
8-K
Closes $150M notes, kills credit line
Bowhead Specialty Holdings completed a $150M 7.750% senior notes offering due 2030 on November 25, 2025, paying semi-annual interest from June 2026. It used proceeds for insurance subsidiary capital and general purposes, while terminating its prior credit agreement in full. Notes are senior unsecured. Risks lurk in forward-looking use of proceeds.
8-K
Q3 premiums up 17.5%
Bowhead Specialty Holdings reported Q3 2025 results on November 4, with gross written premiums up 17.5% to $231.5 million, driven by 20.4% casualty growth to $144.7 million and Baleen Specialty surging 83.4% to $6.2 million. Net income hit $15.2 million while combined ratio ticked to 95.4% from 94.4%, reflecting portfolio mix shift toward higher-loss casualty. Growth scales smoothly. Disciplined underwriting holds firm.
IPO
Website
Employees
Sector
Industry
ASIC
Ategrity Specialty Insurance Co
20.24+0.13
BNT
Brookfield Wealth Solutions Ltd
45.15-0.13
CNA
CNA Financial Corporation
47.13-0.16
HIPO
Hippo Holdings Inc.
30.48-0.61
KNSL
Kinsale Capital Group, Inc.
385.16-7.01
MKL
Markel Group Inc.
2140.70-19.52
PLMR
Palomar Holdings, Inc.
127.54+2.02
PRA
ProAssurance Corporation
24.17-0.09
RYAN
Ryan Specialty Holdings, Inc.
53.00-1.19
SKWD
Skyward Specialty Insurance Gro
49.11+0.31